Ross Thomas Salvaris

11PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersTumour immunologyImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.

|May 26, 2026
Significant variations in first-line mantle cell lymphoma care-an Australasian Lymphoma and Related Diseases Registry study.

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

|Feb 13, 2025
BTK Is the Target That Keeps on Giving: A Review of BTK-Degrader Drug Development, Clinical Data, and Future Directions in CLL.

Ross T Salvaris, Jamie Brennan, Katharine L Lewis

|Jun 17, 2024
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.

Masa Lasica, Mary A Anderson, Alex Boussioutas

|Nov 11, 2023
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemia.

Ross Salvaris, Stephen Mulligan, Andrea Puig

Pageof 2

Frequent Collaborators

4 joint publications

Chan Yoon Cheah

3 joint publications

Stephen Opat

3 joint publications

Nada Hamad

3 joint publications

Eliza A Hawkes